Achmea Investment Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-27,763
Closed -$2.76M 463
2023
Q4
$2.76M Sell
27,763
-1,175
-4% -$117K 0.06% 289
2023
Q3
$2.99M Sell
28,938
-17,981
-38% -$1.86M 0.07% 273
2023
Q2
$5.7M Buy
46,919
+11,919
+34% +$1.45M 0.12% 186
2023
Q1
$5.38M Buy
35,000
+1,590
+5% +$244K 0.16% 159
2022
Q4
$5.62M Sell
33,410
-6,570
-16% -$1.11M 0.19% 144
2022
Q3
$4.73M Sell
39,980
-17,664
-31% -$2.09M 0.17% 148
2022
Q2
$8.23M Sell
57,644
-28,073
-33% -$4.01M 0.27% 93
2022
Q1
$14.8M Buy
+85,717
New +$14.8M 0.38% 55
2021
Q4
Sell
-49,235
Closed -$18.9M 447
2021
Q3
$18.9M Buy
49,235
+26,454
+116% +$10.2M 0.58% 30
2021
Q2
$5.35M Buy
22,781
+5,656
+33% +$1.33M 0.18% 154
2021
Q1
$2.24M Buy
17,125
+701
+4% +$91.8K 0.08% 301
2020
Q4
$1.72M Buy
16,424
+7,380
+82% +$771K 0.06% 334
2020
Q3
$640K Sell
9,044
-10,886
-55% -$770K 0.03% 421
2020
Q2
$1.28M Buy
+19,930
New +$1.28M 0.04% 216